Rabeprazole Sodium (Aurobindo Pharma Limited)
Welcome to the PulseAid listing for the Rabeprazole Sodium drug offered from Aurobindo Pharma Limited. This Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Aurobindo Pharma Limited |
| NON-PROPRIETARY NAME: | Rabeprazole Sodium |
| SUBSTANCE NAME: | RABEPRAZOLE SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-02-17 |
| END MARKETING DATE: | 0000-00-00 |
Rabeprazole Sodium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Rabeprazole Sodium from Aurobindo Pharma Limited |
| LABELER NAME: | Aurobindo Pharma Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/1) |
| START MARKETING DATE: | 2017-02-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 65862-721_d11c3211-b4d4-4893-8c1c-b8fb6d0a0b89 |
| PRODUCT NDC: | 65862-721 |
| APPLICATION NUMBER: | ANDA205761 |
Other RABEPRAZOLE SODIUM Pharmaceutical Manufacturers / Labelers:
